A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PS / pathologic stage

[Related PubMed/MEDLINE]
Total Number of Papers: 74
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PS  (>> Co-occurring Abbreviation)
Long Form:   pathologic stage
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1. CT, EUS, MEN1, MRI, NF-PNENs, RS
2018 Systematic differences between ultrasound and pathological evaluation of thyroid nodules: a method comparison study. ---
2018 [The effect of microRNA-21 on myocardial fibrosis in mice with chronic viral myocarditis]. COL1-A1, CVB3, CVF, CVF, CVMC, GFP, i.p, LVEDD, LVEF, LVESD, miR-21, PBS, TGF-beta1
2017 Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. AIC, AJCC, DSS, ER
2017 Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. CS, LRR
2017 [Study on the role of autophagy in heme oxygenase 1 preventing hepatic ischemia/reperfusion injury in rats]. 3-MA, AI, CoPP, HE, HO-1, I/R, RT-PCR, SD, TUNEL, ZnPP
2016 Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy. CS, DFS, ER, NACT, NG, OS
2016 Validation of the CPS+EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. AJCC, AUC, CI, CS, ER, NAC
2013 Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor? CS, NSGCT, RPLND
10  2011 Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. AIC, AJCC, C-index, DSS, EP, ER, PR
11  2011 Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. AJCC, CPS, CS, DSS
12  2006 Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. CT, OR, RS
13  2005 Germ cell testicular tumors in clinical stage A and normal values of serum tumor mark-ers post-orchiectomy: the experience in the management of 300 consecutive patients. ADF, CR, CS-A, GCTT, NSTT, RPLA, RPLN, TS
14  2005 Management of patients with low-stage nonseminomatous germ cell testicular cancer. CS, NSGCT, RPLND
15  2005 Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. ECP, LVI, RPLND
16  2003 Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme. CS, HL, MOPP/ABVD, OS, RFS, RT
17  2003 Early stage infradiaphragmatic Hodgkin's disease: results of radiotherapy and review of the literature. CMT, CS, DFS, HD, IDHD
18  2002 White matter injury after cerebral ischemia in ovine fetuses. GFAP, MBP
19  2001 Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease. CS, FFTF
20  2000 Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer. CS, EC, RPLND
21  2000 RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. QOL, RPLND
22  1999 Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. CMT, CS, HD, MPA
23  1997 Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer. HR, IR, LR, RPLND
24  1996 Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience. CS, IHD
25  1995 Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. LP, NS
26  1995 Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. GS, PSA, PSAST
27  1995 Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate. CaP, PSA
28  1994 An unusual late relapse in pathologic stage I non-seminomatous germ cell tumor: case report and review of the literature. NSGCT, RPLND
29  1994 The importance of staging laparotomy in pediatric Hodgkin's disease. CS
30  1992 Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital. CR, CS, GPR, HD
31  1991 A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up. CR, HD, MVPP, RFS, RT
32  1991 Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. ---
33  1991 Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project. AFP, hCG, LD, RPLND, SWENOTECA
34  1991 Infradiaphragmatic Hodgkin's disease, long term follow-up of a rare presentation. CS, RFS
35  1991 Pathologic stage I and II Hodgkin's disease. Long-term results at three Connecticut hospitals. ---
36  1991 Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. ---
37  1991 Results of a changing treatment philosophy for children with stage I Hodgkin's disease: a 35-year experience. CS, FFR
38  1991 Stage I and II subdiaphragmatic Hodgkin's disease. CS
39  1990 Is pelvic irradiation necessary in stage III1A Hodgkin's disease? ---
40  1990 Prognostic factors for positive surgical staging in patients with Hodgkin's disease. CS, HD, LD, MC
41  1990 Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. MET, NSGCT, Pre-AFP, PS1, RPLND
42  1990 Radiation therapy in the management of bulky mediastinal Hodgkin's disease. MMR
43  1990 Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital. CS, HD, RT
44  1990 Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging, and treatment. CS, HD, OR
45  1990 Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group. BNLI
46  1990 [Evaluation of the role of surgery in 25 patients with metastatic neuroblastoma]. CS
47  1989 Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management. CS, CT, LAG, NHL
48  1989 Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. CS, NS
49  1989 Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. CMT, RT
50  1989 [Results of the treatment of Hodgkin's disease: the importance of establishing and executing a protocol]. ---
51  1989 [Serological and histological study of lupus nephritis with special reference to anti-SSA antibody]. AI, CI, SLE
52  1988 Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. EMRT, M-PA
53  1988 Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. FFR, HD, LP, MC, NS
54  1988 Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. ESR
55  1988 Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. FFP, IF, STLI/TLI, VBM
56  1987 An immunosorbent assay for blood group I antigens in breast carcinoma. BBD, BCa, ELISA, Hy
57  1987 Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. CMT, FFR, JCRT, MMR, SUMC
58  1987 Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients. CS
59  1986 Stage IIB Hodgkin's disease: the Stanford experience. ---
60  1985 Evaluation of the role of surgery in 130 patients with neuroblastoma. CS
61  1984 A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group. RFS
62  1984 Serum cold agglutinin and IgM levels in breast carcinoma. BCa
63  1984 The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years. CR, CS, CT, MVPP, RT
64  1983 Mantel irradiation for stage I and stage II Hodgkin's disease--results of a 10 year experience. CS, RFS
65  1982 Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast. ---
66  1981 Late relapses in Hodgkin disease. CR, HD
67  1981 Survival of patients with localized diffuse histiocytic lymphoma. DHL
68  1980 Clinical versus pathologic stage I and II Hodgkin's disease. CS
69  1980 Is staging laparotomy of therapeutic value in patients with supradiaphragmatic Hodgkins's disease, clinical stage IA-IIA? CS
70  1980 Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. NH
71  1978 Hodgkin's disease: problems of staging. HD
72  1978 Staging laparotomy in Hodgkin's disease. CS
73  1977 Survival of patients with localized histiocytic lymphoma. ---
74  1976 Results of involved field and extended field radiotherapy in patients with pathologic state I and II Hodgkin's disease. CS